Skip to content
About
Board
Management
Business Development
Work at IDT
Pharmaceutical Services
Regulatory Compliance
Tax Incentives
Sterile Facility
Medicinal Cannabis
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
News
Home
»
News
»
IDT – Whistleblower Policy
IDT – Whistleblower Policy
December 19, 2019
|
News
The policy can be viewed here
Posts navigation
← IDT – Whistleblower Policy_181219_FINAL
CAN and IDT announce commercial manufacture FINAL191219 →